| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |